» Articles » PMID: 39483419

Genotypic Diversity Among Typhi Isolated from Children Living in Informal Settlements in Nairobi, Kenya

Overview
Date 2024 Nov 1
PMID 39483419
Authors
Affiliations
Soon will be listed here.
Abstract

The persistence of multidrug-resistant (MDR) Typhi (. Typhi) is a challenge especially in regions where typhoid is endemic. Surveillance of circulating genotypes of MDR . Typhi is crucial in typhoid acute cases and carriers. This study aimed to investigate genotypic diversity of . Typhi from symptomatic and asymptomatic children in endemic settings in Nairobi, Kenya. Symptomatic and asymptomatic individuals' ≤ 16 years were recruited at four health facilities and tested for typhoid through stool cultures. The . Typhi isolates were subjected to antibiotic susceptibility testing to investigate multidrug resistance. The MDR . Typhi isolates' DNA was extracted and illumina sequenced. Raw reads were assembled and analyzed by pathogen-watch. From the 90 sequenced isolates, 60 (67%) were confirmed to be . Typhi (sequence Type 1 and genotype 4.3.1). Out of the 60 . Typhi strains; 39 (65%) had plasmids, from these 38 (97%) had plasmids alone. Out of the 60, 59 (98%) . Typhi isolates had . Point mutations conferring reduced susceptibility to quinolones were detected in 42 (70%) of . Typhi isolates, from these; 14 (33%) had , and 28 (67%) genes, respectively. This study reports 4.3.1 (H58) as the most dominant . Typhi genotype responsible for spread of MDR phenotypes carried on plasmids. Presence of MDR . Typhi with resistance genes such as and reduced susceptibility to ciprofloxacin especially among asymptomatic individuals, reiterates the need for use of typhoid conjugate vaccine among vulnerable children as a control and prevention measure against typhoid.

References
1.
Bentsi-Enchill A, Hombach J . Revised Global Typhoid Vaccination Policy. Clin Infect Dis. 2019; 68(Suppl 1):S31-S33. PMC: 6376084. DOI: 10.1093/cid/ciy927. View

2.
Mengo D, Kariuki S, Muigai A, Revathi G . Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries. 2010; 4(6):393-6. View

3.
Nampota-Nkomba N, Nyirenda O, Khonde L, Mapemba V, Mbewe M, Ndaferankhande J . Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial. Lancet Glob Health. 2022; 10(9):e1326-e1335. PMC: 9380257. DOI: 10.1016/S2214-109X(22)00275-3. View

4.
Mirza S, Kariuki S, Mamun K, Beeching N, Hart C . Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar typhi from Asia. J Clin Microbiol. 2000; 38(4):1449-52. PMC: 86462. DOI: 10.1128/JCM.38.4.1449-1452.2000. View

5.
Kariuki S, Revathi G, Kiiru J, Mengo D, Mwituria J, Muyodi J . Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol. 2010; 48(6):2171-6. PMC: 2884483. DOI: 10.1128/JCM.01983-09. View